Identification |
Name: | 1,3-Propanediol,2-[(5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraen-1-yloxy]- |
Synonyms: | 2-[((11Z, 14Z)-Icosa-5, 8, 11, 14-tetraenyl)oxy]-propane-1, 3-diol;2-Arachidonyl glycerol ether;Noladin ether; |
CAS: | 222723-55-9 |
Molecular Formula: | C23H40O3 |
Molecular Weight: | 364.5619 |
InChI: | InChI=1S/C23H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-23(21-24)22-25/h6-7,9-10,12-13,15-16,23-25H,2-5,8,11,14,17-22H2,1H3/b7-6-,10-9-,13-12-,16-15- |
Molecular Structure: |
|
Properties |
Density: | 0.948 g/cm3 |
Refractive index: | 1.502 |
Water Solubility: | 15mg/ml soluble in DMSO or dimethyl formamide; 0.5mg/ml soluble in a 1:1 solution of ethanol:PBS ( 7.2) (dilute the ethanol solution with PBS). |
Solubility: | 15mg/ml soluble in DMSO or dimethyl formamide; 0.5mg/ml soluble in a 1:1 solution of ethanol:PBS ( 7.2) (dilute the ethanol solution with PBS). |
Biological Activity: | Endogenous agonist for the GPR55 and CB 1 receptors (EC 50 values are 10 and 37 nM respectively) that displays selectivity over CB 2 receptors (K i values are 21.2 nM and > 3mM at CB 1 and CB 2 respectively). Causes sedation, hypothermia, intestinal immobility and mild antinociception in vivo . Attenuates sensory neurotransmission in rat mesenteric arteries via GPR55. Also available as part of the Endocannabinoid Tocriset™ . |
Safety Data |
|
|